Janney Montgomery Scott LLC Alaunos Therapeutics, Inc. Transaction History

Janney Montgomery Scott LLC

$35.8 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$0.04 - $0.13 $1,008 - $3,278	-25,218 Reduced 37.7%	41,677 $3,000
Q3 2023 Nov 08, 2023	SELL	$0.12 - $0.5 $168 - $700	-1,400 Reduced 2.05%	66,895 $9,000
Q2 2023 Jul 26, 2023	SELL	$0.43 - $0.65 $3,579 - $5,411	-8,325 Reduced 10.87%	68,295 $35,000
Q1 2023 Apr 28, 2023	BUY	$0.46 - $0.81 $11 - $20	25 Added 0.03%	76,620 $48,000
Q4 2022 Feb 01, 2023	SELL	$0.5 - $261.0 $263 - $137,547	-527 Reduced 0.68%	76,595 $50,000
Q3 2022 Oct 25, 2022	SELL	$1.04 - $322.5 $5,501 - $1.71 Million	-5,290 Reduced 6.42%	77,122 $133,000
Q2 2022 Aug 03, 2022	SELL	$0.41 - $1.24 $820 - $2,480	-2,000 Reduced 2.37%	82,412 $101,000
Q1 2022 May 04, 2022	SELL	$0.62 - $1.17 $148 - $280	-240 Reduced 0.28%	84,412 $55,000
Q4 2021 Jan 27, 2022	SELL	$1.09 - $1.89 $2,427 - $4,209	-2,227 Reduced 2.56%	84,652 $92,000
Q3 2021 Oct 29, 2021	BUY	$1.44 - $2.73 $14 - $27	10 Added 0.01%	86,879 $158,000
Q2 2021 Jul 26, 2021	BUY	$2.63 - $3.67 $3,700 - $5,163	1,407 Added 1.65%	86,869 $229,000
Q1 2021 Apr 27, 2021	SELL	$2.82 - $5.6 $6,556 - $13,020	-2,325 Reduced 2.65%	85,462 $308,000
Q4 2020 Jan 25, 2021	SELL	$2.09 - $3.09 $49,418 - $73,063	-23,645 Reduced 21.22%	87,787 $221,000
Q3 2020 Nov 06, 2020	BUY	$2.39 - $3.43 $21,952 - $31,504	9,185 Added 8.98%	111,432 $281,000
Q2 2020 Jul 23, 2020	SELL	$2.2 - $3.71 $37,444 - $63,144	-17,020 Reduced 14.27%	102,247 $335,000
Q1 2020 Apr 30, 2020	SELL	$1.9 - $4.98 $1,299 - $3,406	-684 Reduced 0.57%	119,267 $292,000
Q4 2019 Jan 21, 2020	BUY	$3.95 - $5.35 $76,037 - $102,987	19,250 Added 19.12%	119,951 $566,000
Q3 2019 Oct 29, 2019	BUY	$4.13 - $6.94 $40,420 - $67,921	9,787 Added 10.77%	100,701 $431,000
Q2 2019 Jul 29, 2019	BUY	$3.98 - $6.2 $35,820 - $55,800	9,000 Added 10.99%	90,914 $530,000
Q1 2019 Apr 30, 2019	BUY	$2.0 - $4.4 $2,276 - $5,007	1,138 Added 1.41%	81,914 $315,000
Q4 2018 Feb 01, 2019	SELL	$1.61 - $3.62 $1,247 - $2,805	-775 Reduced 0.95%	80,776 $151,000
Q3 2018 Nov 05, 2018	SELL	$2.26 - $3.27 $106,538 - $154,151	-47,141 Reduced 36.63%	81,551 $261,000
Q2 2018 Jul 24, 2018	BUY	$3.02 - $4.94 $1,561 - $2,553	517 Added 0.4%	128,692 $389,000
Q1 2018 Apr 19, 2018	SELL	$3.46 - $5.14 $26,918 - $39,989	-7,780 Reduced 5.72%	128,175 $502,000
Q4 2017 Feb 14, 2018	SELL	$4.0 - $6.54 $362,696 - $593,007	-90,674 Reduced 40.01%	135,955 $563,000
Q3 2017 Nov 15, 2017	BUY	$4.99 - $6.57 $1.13 Million - $1.49 Million	226,629	226,629 $1.39 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account